Beyond the Data: REDUCE-AMI
Troels Yndigegn and Sripal Bangalore discuss the inutility of beta-blockers in modern-day post-MI care in patients with preserved EF.
Troels Yndigegn and Sripal Bangalore discuss the inutility of beta-blockers in modern-day post-MI care in patients with preserved EF.
A neutral overall trial result seems to be due to harms in patients with cerebral ischemia and benefits in those with hemorrhages.
This review discusses current evidence regarding the epidemiology, pathophysiology, clinical presentation, diagnosis, and management of heart failure with preserved ejection fraction.
Current Hypertension Reports – To define resistant hypertension (RHT), review its pathophysiology and disease burden, identify barriers to effective hypertension management, and to highlight…
Obesity is a recognized public health epidemic with a prevalence that continues to increase dramatically in nearly all populations, impeding progress in reducing incidence rates…
Comments come as Commission president hints EU could impose tariffs on Chinese electric vehicles
Cette année, pour la fête des mères, on se tourne vers des idées cadeaux savoureuses. Idéales pour être partagées, ces créations gourmandes feront plaisir à…
Register Now for ASNC2024 and Join Us in Austin, Texas, USA, from Sept. 5-7! You are invited to join us for the 29th Annual Scientific Session and…
🙏Srimad Bhagavad Gita Chapter 14 Verse 23🙏A man who is beyond qualities does not make any effort on his own, being situated in his soul🙏Hare…
Despite a greater CAC increase with high dose and long-term statin therapy, events did not occur more frequently in statin treated patients. This suggests that…
AliveCor announced new study results backing its handheld ECG technology at Heart Rhythm Society 2024 in Boston.